Please assess the completion status of the following clinical trial:

Trial Title: Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 5 \< UHDRS \< 50~* Age \> 18 years~* Ability to undergo MR scanning~* Covered by french social security~Exclusion Criteria:~* Evidence of psychiatric disorder~* Attendant neurological disorder~* Contraindications to MRI (claustrophobia, metallic or material implants)~* Severe head injury~* Unable to understand the protocol~* Pregnancy~* Failure to give informed consent~* Subjects with exclusion criteria required by french law (e.g. subjects who require a legally authorized representative to obtain consent)~* Unwillingness to be informed in case of abnormal MRI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Triheptanoin 1g/kg/day (Type: EXPERIMENTAL): All patients received Triheptanoin oil at 1g/kg/day during 1 month

Based on this trial design, predict the completion outcome and termination type (if applicable).